chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: False positive investigation result, Fibrin D dimer normal, Glomerular filtration rate decreased, Hypoxia, Influenza A virus test negative
Clinical narrative: J&J Dose 5/10/21 (lot NA) COVID Positive 1/6/22 (pt reported) COVID Positive 1/20/22  1/20/22: Patient is a 76-year-old male with significant past medical history of diabetes mellitus type 2 - on insulin, coronary artery disease, systolic CHF - pacemaker ICD, paroxysmal atrial fibrillation - on Eliquis, non-Hodgkin's lymphoma, CKD 3B and obstructive sleep apnea. Patient is a nonsmoker nonalcoholic.  Lives with his wife. Able to ambulate without any assistive device .  Able to do all ADLs. Part-time he live in another area.  Recently patient started experiencing exertional shortness of breath, sore throat, dry cough, nasal congestion and stuffiness - upper respiratory like symptoms.  Appetite greatly reduced. Denies nausea vomiting chest pain fever or chills. On January 6th - he was diagnosed with COVID.  He was supposed to get antibody infusion. Patient decided to come here.  His wife drove.   In the emergency room evaluation - at rest, on room air he is saturating 90%.  With minimal activity, desaturating to 85%.  He had no home oxygen dependency.  Baseline creatinine 1.6 worsened to 2.37.  Chest x-ray shows bilateral infiltrates.  Fever 100.7. Influenza a and B negative.  D-dimer normal. With suspicion of superimposed bacterial pneumonia, in ER he  received Rocephin and azithromycin.   I examined patient in emergency room.  Patient is slightly anxious. Answering questions appropriately.  Patient denies having any chest pain, fever or diarrhea.  Said last 3 nights he experiences significant night sweats. Complains of generalized weakness. Discussed with patient about treatment options. Per hospital policy with GFR less than 30, remdesivir is not an option. Will hold diuretic and gently hydrate.  Recheck renal panel in a.m.  If GFR improve, can start on remdesivir.  Ordering Actemra. Patient had history of systolic congestive heart failure.  1/25/22: 76-year-old male with a history of T2 dm on insulin, CAD, systolic CHF, status post AICD placement, PAF on Eliquis, NHL, CKD 3B, morbid obesity and OSA.   He was admitted for acute hypoxia secondary to COVID-19 infection. He was initially diagnosed with COVID-19 on 01/06/2022.  He has been improving with gradual improvement in oxygenation. At this morning he is down to room air with O2 saturation of 94-95%.  He had an oxygen walk for home determination and requires no supplemental oxygen.  Two sets of blood cultures done on admission were positive for coagulase negative Staph but repeat blood culture x2 came back negative indicating the initial positive was a contaminant. He will be discharged on his pre-admission medications.  He will enroll in COVID safe at home program in the meantime.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza B virus test, Lung infiltration, Nasal congestion, Night sweats, Oropharyngeal pain
Clinical narrative: J&J Dose 5/10/21 (lot NA) COVID Positive 1/6/22 (pt reported) COVID Positive 1/20/22  1/20/22: Patient is a 76-year-old male with significant past medical history of diabetes mellitus type 2 - on insulin, coronary artery disease, systolic CHF - pacemaker ICD, paroxysmal atrial fibrillation - on Eliquis, non-Hodgkin's lymphoma, CKD 3B and obstructive sleep apnea. Patient is a nonsmoker nonalcoholic.  Lives with his wife. Able to ambulate without any assistive device .  Able to do all ADLs. Part-time he live in another area.  Recently patient started experiencing exertional shortness of breath, sore throat, dry cough, nasal congestion and stuffiness - upper respiratory like symptoms.  Appetite greatly reduced. Denies nausea vomiting chest pain fever or chills. On January 6th - he was diagnosed with COVID.  He was supposed to get antibody infusion. Patient decided to come here.  His wife drove.   In the emergency room evaluation - at rest, on room air he is saturating 90%.  With minimal activity, desaturating to 85%.  He had no home oxygen dependency.  Baseline creatinine 1.6 worsened to 2.37.  Chest x-ray shows bilateral infiltrates.  Fever 100.7. Influenza a and B negative.  D-dimer normal. With suspicion of superimposed bacterial pneumonia, in ER he  received Rocephin and azithromycin.   I examined patient in emergency room.  Patient is slightly anxious. Answering questions appropriately.  Patient denies having any chest pain, fever or diarrhea.  Said last 3 nights he experiences significant night sweats. Complains of generalized weakness. Discussed with patient about treatment options. Per hospital policy with GFR less than 30, remdesivir is not an option. Will hold diuretic and gently hydrate.  Recheck renal panel in a.m.  If GFR improve, can start on remdesivir.  Ordering Actemra. Patient had history of systolic congestive heart failure.  1/25/22: 76-year-old male with a history of T2 dm on insulin, CAD, systolic CHF, status post AICD placement, PAF on Eliquis, NHL, CKD 3B, morbid obesity and OSA.   He was admitted for acute hypoxia secondary to COVID-19 infection. He was initially diagnosed with COVID-19 on 01/06/2022.  He has been improving with gradual improvement in oxygenation. At this morning he is down to room air with O2 saturation of 94-95%.  He had an oxygen walk for home determination and requires no supplemental oxygen.  Two sets of blood cultures done on admission were positive for coagulase negative Staph but repeat blood culture x2 came back negative indicating the initial positive was a contaminant. He will be discharged on his pre-admission medications.  He will enroll in COVID safe at home program in the meantime.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Oxygen saturation decreased, Pneumonia bacterial, Pyrexia, Renal function test, Respiratory symptom
Clinical narrative: J&J Dose 5/10/21 (lot NA) COVID Positive 1/6/22 (pt reported) COVID Positive 1/20/22  1/20/22: Patient is a 76-year-old male with significant past medical history of diabetes mellitus type 2 - on insulin, coronary artery disease, systolic CHF - pacemaker ICD, paroxysmal atrial fibrillation - on Eliquis, non-Hodgkin's lymphoma, CKD 3B and obstructive sleep apnea. Patient is a nonsmoker nonalcoholic.  Lives with his wife. Able to ambulate without any assistive device .  Able to do all ADLs. Part-time he live in another area.  Recently patient started experiencing exertional shortness of breath, sore throat, dry cough, nasal congestion and stuffiness - upper respiratory like symptoms.  Appetite greatly reduced. Denies nausea vomiting chest pain fever or chills. On January 6th - he was diagnosed with COVID.  He was supposed to get antibody infusion. Patient decided to come here.  His wife drove.   In the emergency room evaluation - at rest, on room air he is saturating 90%.  With minimal activity, desaturating to 85%.  He had no home oxygen dependency.  Baseline creatinine 1.6 worsened to 2.37.  Chest x-ray shows bilateral infiltrates.  Fever 100.7. Influenza a and B negative.  D-dimer normal. With suspicion of superimposed bacterial pneumonia, in ER he  received Rocephin and azithromycin.   I examined patient in emergency room.  Patient is slightly anxious. Answering questions appropriately.  Patient denies having any chest pain, fever or diarrhea.  Said last 3 nights he experiences significant night sweats. Complains of generalized weakness. Discussed with patient about treatment options. Per hospital policy with GFR less than 30, remdesivir is not an option. Will hold diuretic and gently hydrate.  Recheck renal panel in a.m.  If GFR improve, can start on remdesivir.  Ordering Actemra. Patient had history of systolic congestive heart failure.  1/25/22: 76-year-old male with a history of T2 dm on insulin, CAD, systolic CHF, status post AICD placement, PAF on Eliquis, NHL, CKD 3B, morbid obesity and OSA.   He was admitted for acute hypoxia secondary to COVID-19 infection. He was initially diagnosed with COVID-19 on 01/06/2022.  He has been improving with gradual improvement in oxygenation. At this morning he is down to room air with O2 saturation of 94-95%.  He had an oxygen walk for home determination and requires no supplemental oxygen.  Two sets of blood cultures done on admission were positive for coagulase negative Staph but repeat blood culture x2 came back negative indicating the initial positive was a contaminant. He will be discharged on his pre-admission medications.  He will enroll in COVID safe at home program in the meantime.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Staphylococcus test positive, Superinfection
Clinical narrative: J&J Dose 5/10/21 (lot NA) COVID Positive 1/6/22 (pt reported) COVID Positive 1/20/22  1/20/22: Patient is a 76-year-old male with significant past medical history of diabetes mellitus type 2 - on insulin, coronary artery disease, systolic CHF - pacemaker ICD, paroxysmal atrial fibrillation - on Eliquis, non-Hodgkin's lymphoma, CKD 3B and obstructive sleep apnea. Patient is a nonsmoker nonalcoholic.  Lives with his wife. Able to ambulate without any assistive device .  Able to do all ADLs. Part-time he live in another area.  Recently patient started experiencing exertional shortness of breath, sore throat, dry cough, nasal congestion and stuffiness - upper respiratory like symptoms.  Appetite greatly reduced. Denies nausea vomiting chest pain fever or chills. On January 6th - he was diagnosed with COVID.  He was supposed to get antibody infusion. Patient decided to come here.  His wife drove.   In the emergency room evaluation - at rest, on room air he is saturating 90%.  With minimal activity, desaturating to 85%.  He had no home oxygen dependency.  Baseline creatinine 1.6 worsened to 2.37.  Chest x-ray shows bilateral infiltrates.  Fever 100.7. Influenza a and B negative.  D-dimer normal. With suspicion of superimposed bacterial pneumonia, in ER he  received Rocephin and azithromycin.   I examined patient in emergency room.  Patient is slightly anxious. Answering questions appropriately.  Patient denies having any chest pain, fever or diarrhea.  Said last 3 nights he experiences significant night sweats. Complains of generalized weakness. Discussed with patient about treatment options. Per hospital policy with GFR less than 30, remdesivir is not an option. Will hold diuretic and gently hydrate.  Recheck renal panel in a.m.  If GFR improve, can start on remdesivir.  Ordering Actemra. Patient had history of systolic congestive heart failure.  1/25/22: 76-year-old male with a history of T2 dm on insulin, CAD, systolic CHF, status post AICD placement, PAF on Eliquis, NHL, CKD 3B, morbid obesity and OSA.   He was admitted for acute hypoxia secondary to COVID-19 infection. He was initially diagnosed with COVID-19 on 01/06/2022.  He has been improving with gradual improvement in oxygenation. At this morning he is down to room air with O2 saturation of 94-95%.  He had an oxygen walk for home determination and requires no supplemental oxygen.  Two sets of blood cultures done on admission were positive for coagulase negative Staph but repeat blood culture x2 came back negative indicating the initial positive was a contaminant. He will be discharged on his pre-admission medications.  He will enroll in COVID safe at home program in the meantime.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Malaise, Nasopharyngitis, Pyrexia, Rhinorrhoea
Clinical narrative: COVID-19. I received my 2nd booster shot on 03/25/2022 and my COVID symptoms started on 06/10/2022 low fever, and sniffled. I felt like I was coming down with a cold. It lasted 2-3 days. On the 06/16/2022 I tested positive. I took ADVIL which helped with my symptoms.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: COVID-19. I received my 2nd booster shot on 03/25/2022 and my COVID symptoms started on 06/10/2022 low fever, and sniffled. I felt like I was coming down with a cold. It lasted 2-3 days. On the 06/16/2022 I tested positive. I took ADVIL which helped with my symptoms.
Age: 1.33
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Adult dose given instead of pediatric dose. Patient monitored for ~20 minutes post administration and no signs/symptoms noted.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after three doses; patient expired Moderna, 2/10/21, Lot #007M20A,  Moderna 3/10/21, Lot #030A21A,   Moderna 11/18/21, Lot #039F21A
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Computerised tomogram thorax normal, Death, Dyspnoea
Clinical narrative: Moderna Dose 1 5/5/21 (lot NA) Moderna Does 2 6/1/21 (lot NA) COVID Positive 2/19/22  2/19/22: Pt, is 71-year-old female past medical history significant for coronary artery disease, hypertension, hypothyroidism, Parkinson's disease, tremor, GERD, anxiety/depression, schizoaffective disorder, and bipolar disorder.   Patient was admitted after she was admitted for COVID pneumonia and stayed for 4-5 day after she presented with fatigue and was found to have low pulse ox of 80%.  Patient was admitted for 5 days and completed antiviral medication with remdesivir and Decadron.  Patient had CT of the chest with no pulmonary emboli at that time   Currently she still feels short of breath but denies any chest pain fever chills or rigors  3/7/22:  I have been reviewing the chart and the long complicated clinical course.  The specialists and family had agreed with comfort measures, the patient expected to not survive after extubation, but has been hanging on with poor responsiveness and no signs of improvement.  Will approach the family about hospice therapy and possible discharge to a hospice facility. UDPATE I have just been informed that the patient passed away at 08.46 pm.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Endotracheal intubation, Fatigue, Hyporesponsive to stimuli, Oxygen saturation decreased, SARS-CoV-2 test positive
Clinical narrative: Moderna Dose 1 5/5/21 (lot NA) Moderna Does 2 6/1/21 (lot NA) COVID Positive 2/19/22  2/19/22: Pt, is 71-year-old female past medical history significant for coronary artery disease, hypertension, hypothyroidism, Parkinson's disease, tremor, GERD, anxiety/depression, schizoaffective disorder, and bipolar disorder.   Patient was admitted after she was admitted for COVID pneumonia and stayed for 4-5 day after she presented with fatigue and was found to have low pulse ox of 80%.  Patient was admitted for 5 days and completed antiviral medication with remdesivir and Decadron.  Patient had CT of the chest with no pulmonary emboli at that time   Currently she still feels short of breath but denies any chest pain fever chills or rigors  3/7/22:  I have been reviewing the chart and the long complicated clinical course.  The specialists and family had agreed with comfort measures, the patient expected to not survive after extubation, but has been hanging on with poor responsiveness and no signs of improvement.  Will approach the family about hospice therapy and possible discharge to a hospice facility. UDPATE I have just been informed that the patient passed away at 08.46 pm.
Age: 3.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product administered to patient of inappropriate age
Clinical narrative: Patient given adult dose of Moderna vaccine instead of pediatric. Monitored post administration ~20 minutes. No signs/symptoms noted.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Blood lactic acid increased, Blood magnesium decreased, COVID-19, Chest X-ray normal, Chest pain
Clinical narrative: Pfizer Dose 1 4/1/21 (EN6198) Pfizer Dose 2 4/23/21 (EW0153) Pfizer Dose 3 10/27/21 (FF2587) COVID Positive 1/4/22  1/4/22: Patient is a pleasant 54-year-old female with past medical history of asthma, hypertension, obesity previous tobacco use comes in with chief complaint of shortness of breath, chills fever, cough.  Clinical picture started suddenly around 3:00 a.m. overnight patient reported symptoms got progressively worse so she came into the emergency department this morning for further evaluation. In ER blood work demonstrated mild lactic acid elevation of 2.1, Mag was 1.2 mild transaminitis, troponin negative EKG sinus tach CBC without significant leukocytosis or anemia. D-dimer was within normal limits.  Influenza swab was negative COVID PCR was obtained pending.  Chest x-ray reportedly without acute derangements.  Per ED provider patient was working hard to breathe tachycardic and was wheezing received antibiotics, breathing treatment Solu-Medrol and IV fluids.  Request was made to admit to medical service for further treatment evaluation.  At bedside patient is lying comfortably in bed has some lightheadedness, no vision change, mild headache no palpitations, chest pain when she gets short of breath, no abdominal pain, no paresthesia.  Has baseline swelling bilateral lower extremities.  Had 1 episode of diarrhea and, no dysuria.  She is unaware of any sick contacts, stays at home to take care of elderly father and special needs child.  Denies tobacco use, social alcohol consumption 3 times a week 1-2 drinks, no marijuana/recreational drugs, no over-the-counter medications.  She reports she has been COVID vaccinated 2 doses plus booster.  No recent travel outside the area. Does not use oxygen at baseline.  Family history otherwise noncontributory to presenting finding.  Reportedly got very dyspneic on ambulation in ED dropped to 90% otherwise was 93% room air but wheezing was working slightly hard to breathe.  1/6/22: Patient admitted for management of COPD exacerbation and COVID infection without oxygen requirement  She was on IV steroids , IV antibiotics for treatment of COPD exacerbation  She was on supportive treatment for COVID. Not qualifying for remdesivir as she is not hypoxic.  Symptoms improved and hemodynamically stable for discharge  Discharge on medrol dose pack, supportive COVID treatments, PO antibiotics and COVID safe home program
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Chronic obstructive pulmonary disease, Condition aggravated, Cough, Diarrhoea
Clinical narrative: Pfizer Dose 1 4/1/21 (EN6198) Pfizer Dose 2 4/23/21 (EW0153) Pfizer Dose 3 10/27/21 (FF2587) COVID Positive 1/4/22  1/4/22: Patient is a pleasant 54-year-old female with past medical history of asthma, hypertension, obesity previous tobacco use comes in with chief complaint of shortness of breath, chills fever, cough.  Clinical picture started suddenly around 3:00 a.m. overnight patient reported symptoms got progressively worse so she came into the emergency department this morning for further evaluation. In ER blood work demonstrated mild lactic acid elevation of 2.1, Mag was 1.2 mild transaminitis, troponin negative EKG sinus tach CBC without significant leukocytosis or anemia. D-dimer was within normal limits.  Influenza swab was negative COVID PCR was obtained pending.  Chest x-ray reportedly without acute derangements.  Per ED provider patient was working hard to breathe tachycardic and was wheezing received antibiotics, breathing treatment Solu-Medrol and IV fluids.  Request was made to admit to medical service for further treatment evaluation.  At bedside patient is lying comfortably in bed has some lightheadedness, no vision change, mild headache no palpitations, chest pain when she gets short of breath, no abdominal pain, no paresthesia.  Has baseline swelling bilateral lower extremities.  Had 1 episode of diarrhea and, no dysuria.  She is unaware of any sick contacts, stays at home to take care of elderly father and special needs child.  Denies tobacco use, social alcohol consumption 3 times a week 1-2 drinks, no marijuana/recreational drugs, no over-the-counter medications.  She reports she has been COVID vaccinated 2 doses plus booster.  No recent travel outside the area. Does not use oxygen at baseline.  Family history otherwise noncontributory to presenting finding.  Reportedly got very dyspneic on ambulation in ED dropped to 90% otherwise was 93% room air but wheezing was working slightly hard to breathe.  1/6/22: Patient admitted for management of COPD exacerbation and COVID infection without oxygen requirement  She was on IV steroids , IV antibiotics for treatment of COPD exacerbation  She was on supportive treatment for COVID. Not qualifying for remdesivir as she is not hypoxic.  Symptoms improved and hemodynamically stable for discharge  Discharge on medrol dose pack, supportive COVID treatments, PO antibiotics and COVID safe home program
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Electrocardiogram abnormal, Fibrin D dimer normal, Full blood count normal
Clinical narrative: Pfizer Dose 1 4/1/21 (EN6198) Pfizer Dose 2 4/23/21 (EW0153) Pfizer Dose 3 10/27/21 (FF2587) COVID Positive 1/4/22  1/4/22: Patient is a pleasant 54-year-old female with past medical history of asthma, hypertension, obesity previous tobacco use comes in with chief complaint of shortness of breath, chills fever, cough.  Clinical picture started suddenly around 3:00 a.m. overnight patient reported symptoms got progressively worse so she came into the emergency department this morning for further evaluation. In ER blood work demonstrated mild lactic acid elevation of 2.1, Mag was 1.2 mild transaminitis, troponin negative EKG sinus tach CBC without significant leukocytosis or anemia. D-dimer was within normal limits.  Influenza swab was negative COVID PCR was obtained pending.  Chest x-ray reportedly without acute derangements.  Per ED provider patient was working hard to breathe tachycardic and was wheezing received antibiotics, breathing treatment Solu-Medrol and IV fluids.  Request was made to admit to medical service for further treatment evaluation.  At bedside patient is lying comfortably in bed has some lightheadedness, no vision change, mild headache no palpitations, chest pain when she gets short of breath, no abdominal pain, no paresthesia.  Has baseline swelling bilateral lower extremities.  Had 1 episode of diarrhea and, no dysuria.  She is unaware of any sick contacts, stays at home to take care of elderly father and special needs child.  Denies tobacco use, social alcohol consumption 3 times a week 1-2 drinks, no marijuana/recreational drugs, no over-the-counter medications.  She reports she has been COVID vaccinated 2 doses plus booster.  No recent travel outside the area. Does not use oxygen at baseline.  Family history otherwise noncontributory to presenting finding.  Reportedly got very dyspneic on ambulation in ED dropped to 90% otherwise was 93% room air but wheezing was working slightly hard to breathe.  1/6/22: Patient admitted for management of COPD exacerbation and COVID infection without oxygen requirement  She was on IV steroids , IV antibiotics for treatment of COPD exacerbation  She was on supportive treatment for COVID. Not qualifying for remdesivir as she is not hypoxic.  Symptoms improved and hemodynamically stable for discharge  Discharge on medrol dose pack, supportive COVID treatments, PO antibiotics and COVID safe home program
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypertransaminasaemia, Inappropriate schedule of product administration, Influenza virus test negative, Oxygen saturation decreased
Clinical narrative: Pfizer Dose 1 4/1/21 (EN6198) Pfizer Dose 2 4/23/21 (EW0153) Pfizer Dose 3 10/27/21 (FF2587) COVID Positive 1/4/22  1/4/22: Patient is a pleasant 54-year-old female with past medical history of asthma, hypertension, obesity previous tobacco use comes in with chief complaint of shortness of breath, chills fever, cough.  Clinical picture started suddenly around 3:00 a.m. overnight patient reported symptoms got progressively worse so she came into the emergency department this morning for further evaluation. In ER blood work demonstrated mild lactic acid elevation of 2.1, Mag was 1.2 mild transaminitis, troponin negative EKG sinus tach CBC without significant leukocytosis or anemia. D-dimer was within normal limits.  Influenza swab was negative COVID PCR was obtained pending.  Chest x-ray reportedly without acute derangements.  Per ED provider patient was working hard to breathe tachycardic and was wheezing received antibiotics, breathing treatment Solu-Medrol and IV fluids.  Request was made to admit to medical service for further treatment evaluation.  At bedside patient is lying comfortably in bed has some lightheadedness, no vision change, mild headache no palpitations, chest pain when she gets short of breath, no abdominal pain, no paresthesia.  Has baseline swelling bilateral lower extremities.  Had 1 episode of diarrhea and, no dysuria.  She is unaware of any sick contacts, stays at home to take care of elderly father and special needs child.  Denies tobacco use, social alcohol consumption 3 times a week 1-2 drinks, no marijuana/recreational drugs, no over-the-counter medications.  She reports she has been COVID vaccinated 2 doses plus booster.  No recent travel outside the area. Does not use oxygen at baseline.  Family history otherwise noncontributory to presenting finding.  Reportedly got very dyspneic on ambulation in ED dropped to 90% otherwise was 93% room air but wheezing was working slightly hard to breathe.  1/6/22: Patient admitted for management of COPD exacerbation and COVID infection without oxygen requirement  She was on IV steroids , IV antibiotics for treatment of COPD exacerbation  She was on supportive treatment for COVID. Not qualifying for remdesivir as she is not hypoxic.  Symptoms improved and hemodynamically stable for discharge  Discharge on medrol dose pack, supportive COVID treatments, PO antibiotics and COVID safe home program
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Pyrexia, SARS-CoV-2 test positive, Sinus tachycardia, Tachycardia
Clinical narrative: Pfizer Dose 1 4/1/21 (EN6198) Pfizer Dose 2 4/23/21 (EW0153) Pfizer Dose 3 10/27/21 (FF2587) COVID Positive 1/4/22  1/4/22: Patient is a pleasant 54-year-old female with past medical history of asthma, hypertension, obesity previous tobacco use comes in with chief complaint of shortness of breath, chills fever, cough.  Clinical picture started suddenly around 3:00 a.m. overnight patient reported symptoms got progressively worse so she came into the emergency department this morning for further evaluation. In ER blood work demonstrated mild lactic acid elevation of 2.1, Mag was 1.2 mild transaminitis, troponin negative EKG sinus tach CBC without significant leukocytosis or anemia. D-dimer was within normal limits.  Influenza swab was negative COVID PCR was obtained pending.  Chest x-ray reportedly without acute derangements.  Per ED provider patient was working hard to breathe tachycardic and was wheezing received antibiotics, breathing treatment Solu-Medrol and IV fluids.  Request was made to admit to medical service for further treatment evaluation.  At bedside patient is lying comfortably in bed has some lightheadedness, no vision change, mild headache no palpitations, chest pain when she gets short of breath, no abdominal pain, no paresthesia.  Has baseline swelling bilateral lower extremities.  Had 1 episode of diarrhea and, no dysuria.  She is unaware of any sick contacts, stays at home to take care of elderly father and special needs child.  Denies tobacco use, social alcohol consumption 3 times a week 1-2 drinks, no marijuana/recreational drugs, no over-the-counter medications.  She reports she has been COVID vaccinated 2 doses plus booster.  No recent travel outside the area. Does not use oxygen at baseline.  Family history otherwise noncontributory to presenting finding.  Reportedly got very dyspneic on ambulation in ED dropped to 90% otherwise was 93% room air but wheezing was working slightly hard to breathe.  1/6/22: Patient admitted for management of COPD exacerbation and COVID infection without oxygen requirement  She was on IV steroids , IV antibiotics for treatment of COPD exacerbation  She was on supportive treatment for COVID. Not qualifying for remdesivir as she is not hypoxic.  Symptoms improved and hemodynamically stable for discharge  Discharge on medrol dose pack, supportive COVID treatments, PO antibiotics and COVID safe home program
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Troponin normal, Wheezing
Clinical narrative: Pfizer Dose 1 4/1/21 (EN6198) Pfizer Dose 2 4/23/21 (EW0153) Pfizer Dose 3 10/27/21 (FF2587) COVID Positive 1/4/22  1/4/22: Patient is a pleasant 54-year-old female with past medical history of asthma, hypertension, obesity previous tobacco use comes in with chief complaint of shortness of breath, chills fever, cough.  Clinical picture started suddenly around 3:00 a.m. overnight patient reported symptoms got progressively worse so she came into the emergency department this morning for further evaluation. In ER blood work demonstrated mild lactic acid elevation of 2.1, Mag was 1.2 mild transaminitis, troponin negative EKG sinus tach CBC without significant leukocytosis or anemia. D-dimer was within normal limits.  Influenza swab was negative COVID PCR was obtained pending.  Chest x-ray reportedly without acute derangements.  Per ED provider patient was working hard to breathe tachycardic and was wheezing received antibiotics, breathing treatment Solu-Medrol and IV fluids.  Request was made to admit to medical service for further treatment evaluation.  At bedside patient is lying comfortably in bed has some lightheadedness, no vision change, mild headache no palpitations, chest pain when she gets short of breath, no abdominal pain, no paresthesia.  Has baseline swelling bilateral lower extremities.  Had 1 episode of diarrhea and, no dysuria.  She is unaware of any sick contacts, stays at home to take care of elderly father and special needs child.  Denies tobacco use, social alcohol consumption 3 times a week 1-2 drinks, no marijuana/recreational drugs, no over-the-counter medications.  She reports she has been COVID vaccinated 2 doses plus booster.  No recent travel outside the area. Does not use oxygen at baseline.  Family history otherwise noncontributory to presenting finding.  Reportedly got very dyspneic on ambulation in ED dropped to 90% otherwise was 93% room air but wheezing was working slightly hard to breathe.  1/6/22: Patient admitted for management of COPD exacerbation and COVID infection without oxygen requirement  She was on IV steroids , IV antibiotics for treatment of COPD exacerbation  She was on supportive treatment for COVID. Not qualifying for remdesivir as she is not hypoxic.  Symptoms improved and hemodynamically stable for discharge  Discharge on medrol dose pack, supportive COVID treatments, PO antibiotics and COVID safe home program
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines; patient expired Moderna 1/12/21 Lot# 027L20A;   Moderna 2/9/21 Lot#010M20A
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site reaction, Injection site swelling, Injection site warmth
Clinical narrative: INJECTION SITE REACTION. SWOLLEN, ENLARGED, REG AND WARM AROUND ENITRE DELTOID. PT SAID CAME ON A COUPLE DAYS AFTER INJECTION, AND EVENTUALLY WENT DOWN AFTER ABOUT 5 DAYS OF TYLENOL AND REPEATED ICINGS.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: Pt admitted to hospital after presenting to ED with SOB and weakness. He tested positive on home COVID test. He has been vaccinated and boosted against COVID. Pt started on dexamethasone and Remdesivir, Pt is currently on 3L O2. He is still hospitalized
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Nasal congestion, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Covid Breakthrough case. Vaccinated with Pfizer x 3. c/o nasal congestion, cough. Not a candidate for Paxlovid due to greater than 5 days with symptoms. Seen by clinic.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Aspiration, Bacteraemia, COVID-19, Death, Depressed level of consciousness
Clinical narrative: Pfizer Dose 1 2/12/21 (EN6201) Pfizer Dose 2 3/7/21 (EN6199) COVID Positive 1/7/22  1/7/22: 83-year-old lady presented hospital with history of increasing shortness of breath overnight.  Staff at nursing home noted that the patient was struggling with breathing, oxygen saturation dropped to 78.  She was put on 2 L and that improved and placed on CPAP.  The patient was transferred to the emergency department for further management. Apparently, patient tested positive for COVID last week and has not had any symptom until last evening.  In the emergency room, patient was noted to be desaturating.  Currently has been put on BiPAP, saturating 92% on BiPAP. Patient is a poor historian.  Her daughter reports that she is DNR, DNI, but has agreed that the patient is set up for BiPAP use.  The patient has a history of multiple myeloma, chronic anemia, and CKD.  1/13/22: An 83-year-old lady presented to the emergency room with history of increasing shortness of breath.  She had a history of multiple myeloma with severe __________ and severe malnutrition.  The patient's exam was suggestive of pneumonia, malnutrition, COVID-19 infection. Further lab workup revealed that the patient had bacteremia due to Enterococcus faecalis.  The patient's antibiotic therapy was adjusted.  She was on and off BiPAP.  Her oxygen saturation improved with BiPAP up to 2 L; however, she remained very deconditioned.  She required nutrition via TPN and p.r.n. by mouth.  The patient, unfortunately, overnight, suddenly aspirated, and respiratory status worsened.  She remained obtunded and unconscious following that episode.  After discussion with the family about the prognosis, family opted for comfort measures, that were initiated. The patient eventually passed away on January 13, 2022, at 1:10 p.m. the family members were at the bedside at time of passing.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Enterococcal infection, Enterococcus test positive, Inappropriate schedule of product administration, Loss of consciousness
Clinical narrative: Pfizer Dose 1 2/12/21 (EN6201) Pfizer Dose 2 3/7/21 (EN6199) COVID Positive 1/7/22  1/7/22: 83-year-old lady presented hospital with history of increasing shortness of breath overnight.  Staff at nursing home noted that the patient was struggling with breathing, oxygen saturation dropped to 78.  She was put on 2 L and that improved and placed on CPAP.  The patient was transferred to the emergency department for further management. Apparently, patient tested positive for COVID last week and has not had any symptom until last evening.  In the emergency room, patient was noted to be desaturating.  Currently has been put on BiPAP, saturating 92% on BiPAP. Patient is a poor historian.  Her daughter reports that she is DNR, DNI, but has agreed that the patient is set up for BiPAP use.  The patient has a history of multiple myeloma, chronic anemia, and CKD.  1/13/22: An 83-year-old lady presented to the emergency room with history of increasing shortness of breath.  She had a history of multiple myeloma with severe __________ and severe malnutrition.  The patient's exam was suggestive of pneumonia, malnutrition, COVID-19 infection. Further lab workup revealed that the patient had bacteremia due to Enterococcus faecalis.  The patient's antibiotic therapy was adjusted.  She was on and off BiPAP.  Her oxygen saturation improved with BiPAP up to 2 L; however, she remained very deconditioned.  She required nutrition via TPN and p.r.n. by mouth.  The patient, unfortunately, overnight, suddenly aspirated, and respiratory status worsened.  She remained obtunded and unconscious following that episode.  After discussion with the family about the prognosis, family opted for comfort measures, that were initiated. The patient eventually passed away on January 13, 2022, at 1:10 p.m. the family members were at the bedside at time of passing.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Malnutrition, Oxygen saturation decreased, Physical deconditioning, Pneumonia, Positive airway pressure therapy
Clinical narrative: Pfizer Dose 1 2/12/21 (EN6201) Pfizer Dose 2 3/7/21 (EN6199) COVID Positive 1/7/22  1/7/22: 83-year-old lady presented hospital with history of increasing shortness of breath overnight.  Staff at nursing home noted that the patient was struggling with breathing, oxygen saturation dropped to 78.  She was put on 2 L and that improved and placed on CPAP.  The patient was transferred to the emergency department for further management. Apparently, patient tested positive for COVID last week and has not had any symptom until last evening.  In the emergency room, patient was noted to be desaturating.  Currently has been put on BiPAP, saturating 92% on BiPAP. Patient is a poor historian.  Her daughter reports that she is DNR, DNI, but has agreed that the patient is set up for BiPAP use.  The patient has a history of multiple myeloma, chronic anemia, and CKD.  1/13/22: An 83-year-old lady presented to the emergency room with history of increasing shortness of breath.  She had a history of multiple myeloma with severe __________ and severe malnutrition.  The patient's exam was suggestive of pneumonia, malnutrition, COVID-19 infection. Further lab workup revealed that the patient had bacteremia due to Enterococcus faecalis.  The patient's antibiotic therapy was adjusted.  She was on and off BiPAP.  Her oxygen saturation improved with BiPAP up to 2 L; however, she remained very deconditioned.  She required nutrition via TPN and p.r.n. by mouth.  The patient, unfortunately, overnight, suddenly aspirated, and respiratory status worsened.  She remained obtunded and unconscious following that episode.  After discussion with the family about the prognosis, family opted for comfort measures, that were initiated. The patient eventually passed away on January 13, 2022, at 1:10 p.m. the family members were at the bedside at time of passing.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Pfizer Dose 1 2/12/21 (EN6201) Pfizer Dose 2 3/7/21 (EN6199) COVID Positive 1/7/22  1/7/22: 83-year-old lady presented hospital with history of increasing shortness of breath overnight.  Staff at nursing home noted that the patient was struggling with breathing, oxygen saturation dropped to 78.  She was put on 2 L and that improved and placed on CPAP.  The patient was transferred to the emergency department for further management. Apparently, patient tested positive for COVID last week and has not had any symptom until last evening.  In the emergency room, patient was noted to be desaturating.  Currently has been put on BiPAP, saturating 92% on BiPAP. Patient is a poor historian.  Her daughter reports that she is DNR, DNI, but has agreed that the patient is set up for BiPAP use.  The patient has a history of multiple myeloma, chronic anemia, and CKD.  1/13/22: An 83-year-old lady presented to the emergency room with history of increasing shortness of breath.  She had a history of multiple myeloma with severe __________ and severe malnutrition.  The patient's exam was suggestive of pneumonia, malnutrition, COVID-19 infection. Further lab workup revealed that the patient had bacteremia due to Enterococcus faecalis.  The patient's antibiotic therapy was adjusted.  She was on and off BiPAP.  Her oxygen saturation improved with BiPAP up to 2 L; however, she remained very deconditioned.  She required nutrition via TPN and p.r.n. by mouth.  The patient, unfortunately, overnight, suddenly aspirated, and respiratory status worsened.  She remained obtunded and unconscious following that episode.  After discussion with the family about the prognosis, family opted for comfort measures, that were initiated. The patient eventually passed away on January 13, 2022, at 1:10 p.m. the family members were at the bedside at time of passing.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: hospitalization of fully vaccinated covid positive pt
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Urticaria
Clinical narrative: Pt's father reported that within 24 hours of first dose on 6/6/22 pt had small hive-like rashes on body, mostly between fold of arm at elbow. Pt's father stated that hydrocortisone cream was applied and claritin given. Pt recovered without any complications. Pt and pt's father denied any respiratory involvement, difficulty breathing, or rash on neck, chest, or face. Pt's father stated that hive-like rash reappeared several times throughout the last several weeks when showering and when at the lake but resolved on it's own. Unsure if related to vaccination.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Exposure to SARS-CoV-2, Fatigue, Headache
Clinical narrative: Breakthrough covid case. Pt presented to ER on 6/21/22 with c/o cough, fatigue, headache, fever, congestion and covid exposure by wife. Paxlovid prescribed. DC home
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Respiratory tract congestion, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough covid case. Pt presented to ER on 6/21/22 with c/o cough, fatigue, headache, fever, congestion and covid exposure by wife. Paxlovid prescribed. DC home
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive, Unresponsive to stimuli
Clinical narrative: 06/22/2022 He was not hospitalized at death. He was the captain of a charter boat when he went unresponsive.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Eye swelling, Fatigue, Pruritus, Swelling face
Clinical narrative: Employee developed extreme fatigue 3 hours after vaccine administration.  Went home, fell asleep.  Woke about midnight with redness, swelling to cheeks and eyes; also a generalized itch.  Took Benadryl which helped.  Pt has multiple food allergies and sensitivities to medications.
Age: 83.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, COVID-19, Confusional state, SARS-CoV-2 test positive
Clinical narrative: Patient presented to the emergency department on 5/31 for weakness and increased confusion at home. She tested PCR positive for COVID-19 on 5/31.  She was admitted from 5/31 - 6/10. This meets criteria for VAERS reporting.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram pulmonary abnormal, Anticoagulant therapy, Atrial flutter, COVID-19, Chest discomfort
Clinical narrative: Pfizer Dose 1 6/24/21 (lot NA) Pfizer Dose 2 7/16/21 (lot NA) COVID Positive 1/16/22 COVID Positive 1/18/22  1/18/22: 65-year-old lady who presented to the emergency room with a history of generalized fatigue and palpitation following infusion of antibody for the treatment of COVID.  The patient was diagnosed with COVID 2 days ago on Sunday, 01/16/2022, and was scheduled to get her antibody infusion today.  After the infusion, the patient was noted to have some episode of heart racing, complaining of fatigue.  She was sent to the emergency room for further evaluation.  In the emergency room, she was noted to be tachycardic up to 150.  She did not, however, desaturate.  The patient had a CT of the chest done that shows bilateral pulmonary embolism. Currently, she denies chest pain and denied nausea.  1/21/22: 65-year-old woman who presented complaints of chest discomfort and shortness of breath immediately following monoclonal and antibody infusion for recently diagnosed COVID-19 infection.  She was brought to the emergency department where she was found to be in atrial flutter.  Neatly on CT pulmonary angio angiogram revealed saddle  pulmonary embolism with areas of right middle and lower lobe infarcts.  She was admitted to the hospitalist Service, underwent transthoracic echocardiogram with no evidence of right ventricular strain.  Therapeutic anticoagulation was started with IV heparin and continued for 72 hours before being transition to oral Eliquis for anticoagulation.  Hospital course was remarkable for brief episode of scant hemoptysis and pleurisy which resolved prior to discharge.  No further episodes of arrhythmias were noted during hospital course.  She is in stable medical condition at the time of discharge.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram thorax abnormal, Dyspnoea, Echocardiogram normal, Fatigue, Haemoptysis
Clinical narrative: Pfizer Dose 1 6/24/21 (lot NA) Pfizer Dose 2 7/16/21 (lot NA) COVID Positive 1/16/22 COVID Positive 1/18/22  1/18/22: 65-year-old lady who presented to the emergency room with a history of generalized fatigue and palpitation following infusion of antibody for the treatment of COVID.  The patient was diagnosed with COVID 2 days ago on Sunday, 01/16/2022, and was scheduled to get her antibody infusion today.  After the infusion, the patient was noted to have some episode of heart racing, complaining of fatigue.  She was sent to the emergency room for further evaluation.  In the emergency room, she was noted to be tachycardic up to 150.  She did not, however, desaturate.  The patient had a CT of the chest done that shows bilateral pulmonary embolism. Currently, she denies chest pain and denied nausea.  1/21/22: 65-year-old woman who presented complaints of chest discomfort and shortness of breath immediately following monoclonal and antibody infusion for recently diagnosed COVID-19 infection.  She was brought to the emergency department where she was found to be in atrial flutter.  Neatly on CT pulmonary angio angiogram revealed saddle  pulmonary embolism with areas of right middle and lower lobe infarcts.  She was admitted to the hospitalist Service, underwent transthoracic echocardiogram with no evidence of right ventricular strain.  Therapeutic anticoagulation was started with IV heparin and continued for 72 hours before being transition to oral Eliquis for anticoagulation.  Hospital course was remarkable for brief episode of scant hemoptysis and pleurisy which resolved prior to discharge.  No further episodes of arrhythmias were noted during hospital course.  She is in stable medical condition at the time of discharge.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations, Pleurisy, Pulmonary embolism, Pulmonary infarction, SARS-CoV-2 test positive
Clinical narrative: Pfizer Dose 1 6/24/21 (lot NA) Pfizer Dose 2 7/16/21 (lot NA) COVID Positive 1/16/22 COVID Positive 1/18/22  1/18/22: 65-year-old lady who presented to the emergency room with a history of generalized fatigue and palpitation following infusion of antibody for the treatment of COVID.  The patient was diagnosed with COVID 2 days ago on Sunday, 01/16/2022, and was scheduled to get her antibody infusion today.  After the infusion, the patient was noted to have some episode of heart racing, complaining of fatigue.  She was sent to the emergency room for further evaluation.  In the emergency room, she was noted to be tachycardic up to 150.  She did not, however, desaturate.  The patient had a CT of the chest done that shows bilateral pulmonary embolism. Currently, she denies chest pain and denied nausea.  1/21/22: 65-year-old woman who presented complaints of chest discomfort and shortness of breath immediately following monoclonal and antibody infusion for recently diagnosed COVID-19 infection.  She was brought to the emergency department where she was found to be in atrial flutter.  Neatly on CT pulmonary angio angiogram revealed saddle  pulmonary embolism with areas of right middle and lower lobe infarcts.  She was admitted to the hospitalist Service, underwent transthoracic echocardiogram with no evidence of right ventricular strain.  Therapeutic anticoagulation was started with IV heparin and continued for 72 hours before being transition to oral Eliquis for anticoagulation.  Hospital course was remarkable for brief episode of scant hemoptysis and pleurisy which resolved prior to discharge.  No further episodes of arrhythmias were noted during hospital course.  She is in stable medical condition at the time of discharge.